Skip to main content
. Author manuscript; available in PMC: 2014 Jan 13.
Published in final edited form as: Genes Chromosomes Cancer. 2012 Oct 29;52(3):225–236. doi: 10.1002/gcc.22022

Figure 4.

Figure 4

OKN-007 inhibits TGFB1/SMAD2 and Hedgehog/GLI1 signaling in Huh7 cells. (A) OKN-007 treatment was shown to repress the TGFB1/SMAD2 signaling pathway in Huh7 cells by both SBE reporter luciferase activity assay and immunoblotting for phospho-SMAD2. (B) OKN-007 treatment was shown to suppress the Hh/GLI1 signaling pathway in Huh7 cells by both a GLI reporter luciferase activity assay and immunoblotting for GLI1 protein.